Cutaneous CD56<sup>+</sup> T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma.

Cutaneous CD56⁺ T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma.

Zheng, Yixuan James; Lee, Albert; Pincus, Laura; Ho, Wilson; Vujic, Marin; Ortiz-Urda, Susana.

Afiliação

Zheng YJ; University of California, San Francisco Mt. Zion Cancer Research Center, San Francisco, California.
Lee A; University of California, San Francisco Medical Center, San Francisco, California.
Pincus L; Department of Molecular and Cell Biology, University of California, Berkeley, California.
Ho W; University of California, San Francisco Mt. Zion Cancer Research Center, San Francisco, California.
Vujic M; University of California, San Francisco Medical Center, San Francisco, California.
Ortiz-Urda S; University of California, San Francisco Mt. Zion Cancer Research Center, San Francisco, California.

JAAD Case Rep ; 4(6): 540-542, 2018 Jul.

Article em En | MEDLINE | ID: mdl-29892669

Palavras-chave

CT, computerized tomography; CTCL, cutaneous T-cell lymphoma; CTLA-4, cytotoxic T-lymphocyteassociated protein-4; PD-1, programmed cell death receptor protein-1; antiprogrammed cell death receptor protein 1; cutaneous T-cell lymphoma; melanoma; pembrolizumab; vitiligo

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article